Peptide 'favorites' trend: what TikTok gets wrong about these compounds

What's this video probably claiming?

The caption "What's yours?" is a classic engagement hook in the peptide TikTok space. Based on the category tags and creator context, @pepswithjess is almost certainly inviting followers to share their favorite peptide or peptide stack, likely referencing compounds like BPC-157, TB-500, CJC-1295, ipamorelin, or GHK-Cu. This format normalizes peptide self-experimentation as a lifestyle choice, similar to asking someone their favorite supplement. The implicit message is that everyone is using peptides, everyone has a "go-to," and this is simply a matter of personal preference rather than a clinical decision. That framing skips over the fact that most of these compounds are either unapproved, research-only, or sitting in a significant regulatory gray zone. The "what's yours" framing also subtly suggests these compounds are interchangeable consumer products, which they are not.

What does the science actually show?

The actual research picture on popular TikTok peptides is messy and uneven. BPC-157 has shown real promise in rodent models for tendon and gut healing, but as of 2024, no completed human clinical trials exist. Sikiric et al. published extensively on BPC-157 in animal models across journals including Current Pharmaceutical Design (2018), but translating rat studies to humans is a scientific leap most creators don't acknowledge. TB-500, a synthetic fragment of Thymosin Beta-4, has similar gaps. CJC-1295 and ipamorelin as a stack have shown growth hormone pulse amplification in small human studies, including Walker et al. (2006, Journal of Clinical Endocrinology and Metabolism), but sample sizes were typically under 40 participants and long-term safety data is thin. MK-677, an oral GH secretagogue, has slightly more human data, including Nass et al. (2008, JCEM), but it is not FDA-approved and carries real risks including insulin resistance and fluid retention at common self-administered doses.

Where does the social media noise diverge from clinical reality?

The gap between TikTok peptide culture and clinical reality is significant. On TikTok, these compounds are framed as low-risk performance and recovery tools anyone can order online. In clinical reality, most are not approved for human use in the U.S., and compounded versions vary wildly in purity and concentration. A 2023 analysis by Valisure found dosing inconsistencies in compounded semaglutide products, a warning sign that extends across the compounded peptide market. Stack culture is another problem. Combining CJC-1295, ipamorelin, and BPC-157 simultaneously, which many creators promote, produces no published safety data in combination. Individual compound interactions with the GH axis are complex enough. Running multiple GH secretagogues together without monitoring IGF-1 levels is not a lifestyle choice, it is an unmonitored endocrine experiment. Semax and selank, often discussed in nootropic peptide communities, have some Eastern European research backing, but virtually no rigorous Western RCT data exists for cognitive claims being made online.

What should you actually know?

If you are considering any peptide therapy, the relevant questions are not "which one is your favorite" but rather: Is this compound legal and available through a licensed provider in your jurisdiction? Has a clinician reviewed your baseline labs, including IGF-1, fasting glucose, and relevant biomarkers? Is the compounding pharmacy PCAB-accredited? For GH-axis peptides specifically, unsupervised use carries real risks including elevated IGF-1 levels associated with increased cancer cell proliferation risk, per Renehan et al. (2004, The Lancet). GHK-Cu has a reasonable topical safety profile and some collagen synthesis data from Pickart et al. (2015, Journal of Aging Science), but systemic injectable use is a different calculation entirely. The "what's yours" culture makes peptide self-experimentation feel communal and safe. It is neither regulated nor well-studied enough to be treated as a casual wellness choice.